Skip to main content
Douglas Yee, MD, Oncology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

DouglasYeeMD

Oncology Minneapolis, MN

Breast Cancer, Hematologic Oncology

Professor of Medicine Director, Masonic Cancer Center, University of Minnesota

Dr. Yee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yee's full profile

Already have an account?

  • Office

    Masonic Cancer Center, University of Minnesota
    420 Delaware Street SE
    Minneapolis, MN 55455
    Phone+1 612-626-8487
  • Is this information wrong?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1981 - 1985
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1999 - 2024
  • TX State Medical License
    TX State Medical License 1989 - 2007
  • NC State Medical License
    NC State Medical License 1984 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast Cancer 
    American Society of Clinical Oncology(ASCO), Chicago, Illinois - 8/9/2013
  • The DNA Cytosine Deaminase APOBEC3B Promotes Tamoxifen Resistance in ER-Positive Breast Cancer 
    American Society of Clinical Oncology(ASCO), Los Angeles, California - 8/16/2013

Press Mentions

  • University of Minnesota Team Announced as Finalists for Worldwide Cancer Grand Challenges
    University of Minnesota Team Announced as Finalists for Worldwide Cancer Grand ChallengesJuly 13th, 2021
  • UMN Researchers Discuss New Ethical Dilemmas During the Pandemic
    UMN Researchers Discuss New Ethical Dilemmas During the PandemicMarch 19th, 2021
  • Insulin Receptor Substrate-1 (IRS-1) Mediates Progesterone Receptor-Driven Stemness and Endocrine Resistance in Oestrogen Receptor+ Breast Cancer
    Insulin Receptor Substrate-1 (IRS-1) Mediates Progesterone Receptor-Driven Stemness and Endocrine Resistance in Oestrogen Receptor+ Breast CancerNovember 4th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations